Why did Novartis apply to the FDA to change Zaditor from prescription to OTC?
Zaditor was approved by the FDA in 1999 for sale as a prescription medication. Since its introduction, Zaditor has been used by millions of patients for the temporary prevention of itchy eyes due to allergic conjunctivitis. In 2006 the FDA approved the sale of Zaditor as an OTC product. Because Zaditor is available OTC, patients are able to experience fast, long-lasting relief from itchy eyes without the need for a prescription.
Related Questions
- Will Farma de Colombia’s 15% projected growth be driven by the institutional, prescription, or OTC market?
- Will Farma de Colombia’s 15% projected growth be driven by the institutional, prescription, or OTC market?
- Why did Novartis apply to the FDA to change Zaditor from prescription to OTC?
- Is the medication FDA approved – no prescription needed tramadol?
- Can OTC medicines be marketed without pre-approval from FDA?
- Can OTC medicines be marketed without pre-approval from FDA?
